Publications
214
Citations
1,497
Est. group size
~17
Recurring co-author estimate
Active years
14
Publishing since 2013
Gina M. Sizemore's research focuses on breast cancer, particularly how signaling pathways like PDGF/PDGFRβ and Ral GTPases contribute to tumor growth, metastasis, and spread to the brain. Her work spans laboratory studies of cancer cell biology (such as how tumors secrete growth-promoting factors) as well as clinical/real-world studies of treatment patterns and outcomes for patients with metastatic and brain-metastatic breast cancer.
Publication output was relatively steady (2-8 per year) from 2017-2022, then spiked sharply in 2023 and remained elevated through 2025, indicating a recent surge in research and dissemination activity.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Radiation Treatment Patterns for Breast Cancer Brain Metastases
Research Square · 2026
- Radiation treatment patterns for breast cancer brain metastases: an NCDB analysis
Breast Cancer Research and Treatment · 2026
- Hyperactive Pdgfrβ Signaling Induces Cataractogenesis Via Tgfβ and Stat5-Igf1
SSRN Electronic Journal · 2025
- Hyperactive PDGFRβ signaling induces cataractogenesis via TGFβ and STAT5-IGF1
Developmental Biology · 2025
- Abstract P3-06-18: Novel regulators of PDGF-BB secretion in breast cancer
Clinical Cancer Research · 2025
- Real-world treatment patterns and outcomes in HER2-positive metastatic breast cancer patients with brain metastases.
Journal of Clinical Oncology · 2025
- Abstract P4-12-28: Discovery and Validation of Novel Small G Protein Inhibitor OSURALi for Targeting Triple Negative Breast Cancer
Clinical Cancer Research · 2025
- Abstract P1-06-21: The Ral GTPases regulate the TNBC secretome to drive growth and metastasis
Clinical Cancer Research · 2025
- BSBM-07 PDGFB-TO-PDGFRβ SIGNALING IMPACTS BLOOD-BRAIN BARRIER INTEGRITY AND ANGIOGENESIS IN BREAST CANCER BRAIN METASTASIS
Neuro-Oncology Advances · 2025
- BSBM-08 ASTROCYTE PDGFRβ HYPERACTIVATION IN BREAST CANCER BRAIN METASTASIS
Neuro-Oncology Advances · 2025
- Hepatic protein kinase Cβ antagonizing p38 <sup>MAPK</sup> to activate ERK1/2 to dysregulate biliary lipid composition upon lithogenic stress
American Journal of Physiology-Gastrointestinal and Liver Physiology · 2025
- S2 from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis
2025
- S1 Legend from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis
2025
- S4 Legend from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis
2025
- S3 from TLE3 Sustains Luminal Breast Cancer Lineage Fidelity to Suppress Metastasis
2025
- Cancer Research×17
- Breast Cancer Research×3
- Clinical Cancer Research×3
- Neuro-Oncology Advances×3
- Research Square×3
- Steven T. Sizemore
Medicine · The Ohio State University
- Hélène Le Pommellet
Medicine · The Ohio State University
- Briana To
Medicine · The Ohio State University
- Amanda J. Saraf
Medicine · Indiana University
- Ananya Banerjee
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile